• Connect with RxStrategies at the 2019 Fall Hospital Pharmacy Conference

    RxStrategies will be at the Fall Hospital Pharmacy (HCP) Conference on October 28-30 in Kansas City, MO. Team members Justin Rolling and Rhodie Smith will be networking with peers, attending educational sessions and sharing their expertise in 340B solutions. Learn more about the conference here.   Contact us to connect during the conference and learn… Read more »

  • Let’s Connect: 2019 NWRPCA/CHAMPS Fall Primary Care Conference

    RxStrategies’ Todd Hudnall and Krista Scanlon will attend the 2019 NWRPCA/CHAMPS Fall Primary Care Conference in Seattle. The conference takes place October 5 – 8, and provides education and training, information and resource sharing, coalition building, and program and policy development for like-minded community health professionals and their partners. Learn more about the event here.… Read more »

  • Clinical Insights: September 30, 2019

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Jynneos™ (smallpox and monkeypox vaccine, live, nonreplicating) – New Vaccine Approval – September 24, 2019 – The U.S. Food and Drug Administration announced the approval… Read more »

  • Let’s Connect: APHCA Annual Conference and Expo

    RxStrategies is proud to be a Platinum Presenting Sponsor of Alabama Primary Health Care Association’s (APHCA) Annual Bootcamp, Conference and Expo. The event is the State’s largest annual gathering of community health systems, providers and partners from across the community of care. This year’s annual event, Taking Point, will be held on October 1-3, 2019 at… Read more »

  • Clinical Insights: September 13, 2019

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Ibsrela® (tenapanor) – New Drug Approval – September 12, 2019 – Ardelyx, Inc., announced that the U.S. Food and Drug Administration has approved Ibsrela®… Read more »

  • 340B Insider – August 2019

                    Welcome to the August edition of RxStrategies’ 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. Visit our website to read more.           RECAP: 340B COALITION SUMMER CONFERENCE It was great to connect with so many of our clients and industry leaders… Read more »

  • Clinical Insights: August 29, 2019

    Welcome to RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Nourianz™ (istradefylline) – New Drug Approval – August 27, 2019 – The U.S. Food and Drug Administration approved Nourianz™ (istradefylline) tablets as an add-on treatment… Read more »

  • Meet Us at Cardinal Health’s RBC 2019

    Todd Hudnall and Skip Devanny will represent RxStrategies at Cardinal Health’s RBC 2019 in Nashville, July 17-20. Learn more about RBC by visiting their site. Contact us to connect during the conference, and stop by booth 118 to learn about how our comprehensive solutions help keep your 340B program on the right track.